AIM
AZN icon

AHL Investment Management’s AstraZeneca AZN Stock Holding History

AHL Investment Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-25
Closed -$3K – 73
2021
Q4 		$3K Buy
+25
New +$2.94K ﹤0.01% 285

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

AHL Investment Management's AZN Position: Q1 2022 in Review

AHL Investment Management sold out of AstraZeneca (AZN) in Q1 2022, closing a stake of 25 shares — an estimated $3K sold.

AHL Investment Management first reported a position in AZN in Q4 2021 and held it in 1 quarter. The position peaked at $3K in Q4 2021. 981 funds tracked by Wall St. Rank hold AZN as of Q1 2022.

  • AHL Investment Management reported no remaining AstraZeneca position as of Q1 2022 after selling out during the quarter.
  • AHL Investment Management sold 25 AstraZeneca shares in Q1 2022, an estimated $3K.
  • AHL Investment Management first reported a position in AstraZeneca in Q4 2021 and held it in 1 quarter.
  • AHL Investment Management's AstraZeneca position peaked at $3K in Q4 2021.
  • 981 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2022.

Based on AHL Investment Management's 13F filing for Q1 2022, filed 28 Apr 2022.